...
首页> 外文期刊>Toxicology and Applied Pharmacology >Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin administration and high-fat diet on the body weight and hepatic estrogen metabolism in female C3H/HeN mice.
【24h】

Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin administration and high-fat diet on the body weight and hepatic estrogen metabolism in female C3H/HeN mice.

机译:2,3,7,8-四氯二苯并-对-二恶英给药和高脂饮食对雌性C3H / HeN小鼠体重和肝雌激素代谢的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

We studied the effect of administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) by i.p. injection once every 2 weeks in combination with a high-fat (HF) diet for 8 or 16 weeks on the body and organ weight changes as well as on the hepatic enzyme activity for estrogen metabolism in C3H/HeN female mice. Administration of TCDD at 100 microg/kg b.w. once every 2 weeks for 8 weeks increased the body weight by 46% in the HF diet-fed animals, but not in the regular diet-fed animals. This is the first observation suggesting that TCDD at a high dose (100 microg/kg b.w.), but not at lower doses (1 or 10 microg/kg b.w.), may have a strong obesity-inducing effect in C3H/HeN mice fed an HF diet. While TCDD increased liver weight and decreased thymus weight in animals, these effects were enhanced by feeding animals an HF diet. Metabolism studies showed that TCDD administration for 8 or 16 weeks increased the liver microsomal activity for the 2- and 4-hydroxylation of 17 beta-estradiol in animals fed a control diet, but surprisingly not in animals fed an HF diet. Treatment with TCDD dose-dependently increased the hepatic activity for the O-methylation of catechol estrogens in both control and HF diet-fed animals, and it also decreased the levels of liver microsomal sulfatase activity for hydrolysis of estrone-3-sulfate. TCDD did not significantly affect the hepatic enzyme activity for the glucuronidation or esterification of endogenous estrogens. It is suggested that enhanced metabolic inactivation of endogenous estrogens by hepatic estrogen-metabolizing enzymes in TCDD-treated, control diet-fed animals contributes importantly to the reduced incidence of estrogen-associated tumors in animals treated with TCDD.
机译:我们研究了i.p.给予2,3,7,8-四氯二苯并-p-二恶英(TCDD)的效果。 C2H / HeN雌性小鼠每两周注射一次,并与高脂(HF)饮食结合8或16周,以改变身体和器官的重量以及肝酶对雌激素代谢的活性。 TCDD的施用量为100微克/千克体重在HF饮食喂养的动物中,每2周一次,持续8周使体重增加46%,而在常规饮食喂养的动物中则没有。这是第一个发现,表明高剂量(100 microg / kg bw)的TCDD,而不是低剂量(1或10 microg / kg bw)的TCDD,在喂食C3H / HeN小鼠的C3H / HeN小鼠中可能具有强烈的肥胖诱导作用HF饮食。尽管TCDD增加了动物的肝脏重量,减少了胸腺重量,但通过给动物喂食HF饮食可增强这些作用。代谢研究表明,在以对照饮食喂养的动物中,TCDD给药8周或16周可增加17β-雌二醇的2和4羟基化的肝微粒体活性,但令人惊讶的是,在以HF饮食喂养的动物中,TCDD的摄取却没有。在对照和HF饮食喂养的动物中,用TCDD治疗剂量依赖性地增加了儿茶酚雌激素O-甲基化的肝活性,并且还降低了用于水解雌酮-3-硫酸酯的肝微粒体硫酸酯酶活性的水平。 TCDD对内源性雌激素的葡萄糖醛酸化或酯化没有明显影响肝酶的活性。提示在经TCDD治疗的对照饮食喂养动物中,肝脏雌激素代谢酶可增强内源性雌激素的代谢失活,这对降低经TCDD治疗的动物体内雌激素相关肿瘤的发生率有重要贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号